Senior insider sale
CLO & Secretary at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$104.0K
1K shares
What this filing means
REARDON ANDREW plans to sell 1K shares of LIGAND PHARMACEUTICALS INC valued at approximately $104.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2025ACC: 0001950047-25-003094
Officer· CLO & Secretary
Since Mar 2026
1K
Shares to sell
$104.0K
Approx. market value
1K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
2/14/2025
1KTotal acquired1K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Performance Shares Not Applicable | 1K | — |
| Total | 1K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1K
Market value
$104.0K
5/15/2025
Total
Units
1K
Value
$104.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/15/2025 | 1K | $104.0K | NASDAQ | Planned |
| Total | 1K | $104.0K | ||